Supple Graphene Bio-Platform for point-of-care early detection and monitoring of Alzheimer’s Disease
Digital, Industry & SpaceHORIZON-RIAID: 101120706
EC Contribution
€59,579
Consortium Size
11 orgs
Start Year
2023
▶Summary
2D-BioPAD is a cost-effective, non-invasive point of care/self-testing tool for the early and accurate prognosis (assistive diagnosis) of Alzheimer's Disease, with special focus on earlier stages such as Subjective or Mild Cognitive Impairment (SCI/MCI).
Consortium (11)
🇨🇿 UNIVERZITA PALACKEHO V OLOMOUCICZ
coordinator🇬🇷 ARISTOTELIO PANEPISTIMIO THESSALONIKISGR
partner🇬🇷 ELLINIKI ETAIRIA NOSOY ALZHEIMER KAI SYGGENON DIATARACHON SOMATEIOGR
partner🇩🇰 EVNIA APSDK
partner🇪🇸 FUNDACIO INSTITUT CATALA DE NANOCIENCIA I NANOTECNOLOGIAES
partner🇫🇷 GRAPHEALFR
partner🇫🇮 ITA-SUOMEN YLIOPISTOFI
partner🇫🇷 NOVAPTECHFR
partner🇬🇷 Q-PLAN INTERNATIONAL ADVISORS PCGR
partner🇮🇪 UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLINIE
partner🇩🇪 ZENTRALINSTITUT FUER SEELISCHE GESUNDHEITDE
partner